ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

DMAC DiaMedica Therapeutics Inc

2.59
0.00 (0.00%)
Pre Mercado
Última actualización: 06:08:35
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
DiaMedica Therapeutics Inc DMAC NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 2.59 06:08:35
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.59
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
17/4/202415:08BWDiaMedica Therapeutics Announces First Patient Dosed in..
19/3/202415:15BWDiaMedica Therapeutics Provides a Business Update and..
29/1/202415:13BWDiaMedica Therapeutics Announces Poster Presentation at..
23/1/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202415:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/1/202407:23BWDiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as..
02/1/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:52EDGAR2Form 8-K - Current report
13/11/202315:28BWDiaMedica Therapeutics Provides a Business Update and..
09/11/202307:25BWDiaMedica Therapeutics to Attend the 14th Annual..
06/11/202307:23BWDiaMedica Therapeutics to Report Third Quarter 2023..
12/9/202307:13BWDiaMedica Therapeutics Announces the Appointment of Ambarish..
06/9/202307:35BWDiaMedica Therapeutics to Participate at Lake Street’s 7th..
05/9/202315:15EDGAR2Form 8-K - Current report
14/8/202315:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:25EDGAR2Form 8-K - Current report
14/8/202315:13BWDiaMedica Therapeutics Provides a Business Update and..
08/8/202307:32BWDiaMedica Therapeutics to Report Second Quarter 2023..
18/7/202307:30BWDiaMedica Therapeutics to Attend the American Academy of..
10/7/202315:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/7/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
30/6/202315:16EDGAR2Form S-3 - Registration statement under Securities Act of..
26/6/202307:30BWDiaMedica Therapeutics Announces Closing of $37.5 Million..
21/6/202307:39BWDiaMedica Therapeutics Announces $37.5 Million Private..
21/6/202307:15BWDiaMedica Therapeutics Announces that the FDA Has Removed..
30/5/202307:29BWDiaMedica Therapeutics Announces Appointment of Dr. Richard..
15/5/202315:28BWDiaMedica Therapeutics Provides a Business Update and..
08/5/202307:50BWDiaMedica Therapeutics to Report First Quarter 2023..

Su Consulta Reciente

Delayed Upgrade Clock